Reply to "High frequency of Antiphospholipid Antibodies in Critically ill COVID-19 patients: a Link with Hypercoagulability?"

J Intern Med. 2021 Mar;289(3):425-426. doi: 10.1111/joim.13159. Epub 2020 Sep 9.

Authors

L Suárez-Pérez¹, R Coto-Hernández², C Suárez-Cuervo¹, L Caminal-Montero^{2

3}

Affiliations

¹ From, Área de Gestión Clínica de Medicina Interna, Hospital Universitario Central de Asturias, Oviedo, Spain.
² Área de Gestión Clínica de Medicina Interna, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario Central de Asturias, Oviedo, Spain.
³ Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.

PMID: 32909292
DOI: 10.1111/joim.13159

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Antiphospholipid
COVID-19*
Critical Illness
Humans
SARS-CoV-2
Thrombophilia*

Substances

Antibodies, Antiphospholipid